References

You can view the abstracts for the references listed below via the National Library of Medicine's PubMed service. Just click the PubMed links. Click here to view the PubMed disclaimer and copyright notice.

  1. Ashkenazi A. Targeting death and decoy receptors of the tumor-necrosis factor superfamily. Nat Rev Cancer 2002;2:420–430.
    Link to abstract on PubMed
  2. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. Cancer J Clin 2005;55:178–194.
    Link to abstract on PubMed
  3. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312–1316.
    Link to abstract on PubMed
  4. Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest 2005;115:2665–2672.
    Link to abstract on PubMed
  5. Deveraux QL, Reed JC. IAP family proteins—suppressors of apoptosis. Genes Dev 1999;13:239–252.
    Link to abstract on PubMed
  6. Peter ME. The flip side of FLIP. Biochem J 2004;382(Pt 2):e1–3.
    Link to abstract on PubMed
  7. Coultas L, Strasser A. The role of the Bcl-2 protein family in cancer. Semin Cancer Biol 2003;13:115–123.
    Link to abstract on PubMed
  8. Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006;25:4798–4811.
    Link to abstract on PubMed
  9. Letai A. Pharmacological manipulation of Bcl-2 family members to control cell death. J Clin Invest 2005;115:2648–2655.
    Link to abstract on PubMed
  10. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312–1316.
    Link to abstract on PubMed
  11. Coultas L, Strasser A. The role of the Bcl-2 protein family in cancer. Semin Cancer Biol 2003;13:115–123.
    Link to abstract on PubMed
  12. Reed JC. Bcl-2 family proteins. Oncogene 1998;17:3225–3236.
    Link to abstract on PubMed
  13. Bush JA, Li G. The role of Bcl-2 family members in the progression of cutaneous melanoma. Clin Exp Metastasis 2003;20:531–539.
    Link to abstract on PubMed
  14. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002;2:277–288.
    Link to abstract on PubMed
  15. Karst AM, Li G. BH3-only proteins in tumorigenesis and malignant melanoma. Cell Mol Life Sci 2007;64:318–330.
    Link to abstract on PubMed
  16. Henry-Mowatt J, Dive C, Martinou JC, James D. Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene 2004;23:2850–2860.
    Link to abstract on PubMed
  17. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z, Alnemri ES. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 2000;275:36152–36157.
    Link to abstract on PubMed
  18. Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004;64:7183–7190.
    Link to abstract on PubMed
  19. Debatin KM, Krammer PH. Death receptors in chemotherapy and cancer. Oncogene 2004;23:2950–2966.
    Link to abstract on PubMed
  20. Rowinsky EK. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol 2005;23:9394–9407.
    Link to abstract on PubMed
  21. Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M. APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett 1998;427:124–128.
    Link to abstract on PubMed
  22. Ravi R, Jain AJ, Schulick RD, Pham V, Prouser TS, Allen H, et al. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. Cancer Res 2004;64:9105–9114.
    Link to abstract on PubMed
  23. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995;270:7795–7798.
    Link to abstract on PubMed
  24. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505–512.
    Link to abstract on PubMed
  25. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995;14:5579–5588.
    Link to abstract on PubMed
  26. Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci U S A 2001;98:13884–13888.
    Link to abstract on PubMed
  27. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789–799.
    Link to abstract on PubMed
  28. Reed JC. Bcl-2 family proteins. Oncogene 1998;17:3225–3236.
    Link to abstract on PubMed
  29. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;63:119–125.
    Link to abstract on PubMed
  30. Askew D, Ashmun R, Simmons B, Cleveland J. Constitutive c-myc expression in IL-3-dependent myeloid cell line suppresses cycle arrest and accelerates apoptosis. Oncogene 1991;6:1915–1922.
    Link to abstract on PubMed
  31. Klefstrom J, Vastrik I, Saksela E, Valle J, Eilers M, Alitalo K. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-α. EMBO J 1994;13:5442–5450.
    Link to abstract on PubMed
  32. Lutz W, Fulda S, Jeremias I, Debatin KM, Schwab M. MycN and IFNγ cooperate in apoptosis of human neuroblastoma cells. Oncogene 1998;17:339–346.
    Link to abstract on PubMed
  33. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342–348.
    Link to abstract on PubMed